HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer

BACKGROUND: To investigate the feasibility of gene therapy in treating Epstein-Barr virus (EBV)-associated cancer by employing the suicide gene, herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV), which uses the signaling pathway through the HIV-long terminal repeat (LTR) gene which is e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lifang, Yang, Min, Tang, Midan, Ai, Ya, Cao
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562992/
https://www.ncbi.nlm.nih.gov/pubmed/18811956
http://dx.doi.org/10.1186/1756-9966-27-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562992/
https://www.ncbi.nlm.nih.gov/pubmed/18811956
http://dx.doi.org/10.1186/1756-9966-27-42

Ejemplares similares